Investigating the Role of Serotonin in the Mechanism of Action of Psilocybin in Patients With Major Depressive Disorder
Phase: PHASE2 | Sponsor: Icahn School of Medicine at Mount Sinai | Compound: Psilocybin
- Status
- recruiting
- Institution
- Icahn School of Medicine at Mount Sinai
- Start date
- 2025-02-25
- End date
- 2028-03-01
- Registry ID
- NCT06592833
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.